Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Altered dopamine release and monoamine transporters in Vps35 p.D620N knock-in mice
Stefano Cataldi, Jordan Follett, Jesse D. Fox, et al.
npj Parkinson s Disease (2018) Vol. 4, Iss. 1
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Mitochondrial Dysfunction in Parkinson’s Disease—Cause or Consequence?
Chun Chen, Douglass M. Turnbull, Amy K. Reeve
Biology (2019) Vol. 8, Iss. 2, pp. 38-38
Open Access | Times Cited: 225
Impaired dopamine release in Parkinson’s disease
Kaitlyn M. L. Cramb, Dayne Beccano-Kelly, Stephanie J. Cragg, et al.
Brain (2023) Vol. 146, Iss. 8, pp. 3117-3132
Open Access | Times Cited: 91
α7‐Nicotinic Acetylcholine Receptor and Mutated α‐Synuclein Interact in Motor Behaviour and Nigrostriatal Dopamine—Findings With Potential Relevance for a Protective Effect of Cigarette Smoking and Parkinson's Disease
Christian Pifl, Alexandra Wolf, Mark Elevado, et al.
European Journal of Neuroscience (2025) Vol. 61, Iss. 6
Open Access | Times Cited: 3
Parkinson’s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration
Xi Chen, Jennifer K. Kordich, Erin T. Williams, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 12, pp. 5765-5774
Open Access | Times Cited: 98
Dynamic control of the dopamine transporter in neurotransmission and homeostasis
Mengfei Bu, Matthew J. Farrer, Habibeh Khoshbouei
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 93
Coatopathies: Genetic Disorders of Protein Coats
Esteban C. Dell’Angelica, Juan S. Bonifacino
Annual Review of Cell and Developmental Biology (2019) Vol. 35, Iss. 1, pp. 131-168
Open Access | Times Cited: 88
PARK Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson’s Disease
Wen Li, YuHong Fu, Glenda M. Halliday, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 70
Emerging concepts of mitochondrial dysfunction in Parkinson’s disease progression: Pathogenic and therapeutic implications
Linchi Rani, Amal Chandra Mondal
Mitochondrion (2019) Vol. 50, pp. 25-34
Closed Access | Times Cited: 60
Understanding the contributions of VPS35 and the retromer in neurodegenerative disease
Erin T. Williams, Xi Chen, P. Anthony Otero, et al.
Neurobiology of Disease (2022) Vol. 170, pp. 105768-105768
Open Access | Times Cited: 33
The Role of VPS35 in the Pathobiology of Parkinson’s Disease
Jenny Sassone, Chiara Reale, Giovanna Dati, et al.
Cellular and Molecular Neurobiology (2020) Vol. 41, Iss. 2, pp. 199-227
Closed Access | Times Cited: 48
Contributions of VPS35 Mutations to Parkinson’s Disease
Abir A. Rahman, Brad E. Morrison
Neuroscience (2019) Vol. 401, pp. 1-10
Open Access | Times Cited: 47
Acquired dysregulation of dopamine homeostasis reproduces features of Parkinson’s disease
Meghan L. Bucher, Caitlyn W. Barrett, Connor Moon, et al.
npj Parkinson s Disease (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 44
Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease
Dongbing Lai, Babak Alipanahi, Pierre Fontanillas, et al.
Annals of Neurology (2021) Vol. 90, Iss. 1, pp. 76-88
Open Access | Times Cited: 41
VPS35 and retromer dysfunction in Parkinson's disease
Jordan Rowlands, Darren J. Moore
Philosophical Transactions of the Royal Society B Biological Sciences (2024) Vol. 379, Iss. 1899
Open Access | Times Cited: 6
Retromer regulates the lysosomal clearance of MAPT/tau
Julian M. Carosi, Leanne K. Hein, Mark van den Hurk, et al.
Autophagy (2020) Vol. 17, Iss. 9, pp. 2217-2237
Open Access | Times Cited: 35
(D620N) VPS35 causes the impairment of Wnt/β-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model
Ching‐Chi Chiu, Yi-Hsin Weng, Ying‐Zu Huang, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 35
VPS35 D620N knockin mice recapitulate cardinal features of Parkinson’s disease
Mengyue Niu, Fanpeng Zhao, Karina S. Bondelid, et al.
Aging Cell (2021) Vol. 20, Iss. 5
Open Access | Times Cited: 31
Autophagy as a gateway for the effects of methamphetamine: From neurotransmitter release and synaptic plasticity to psychiatric and neurodegenerative disorders
Fiona Limanaqi, Carla L. Busceti, Roberta Celli, et al.
Progress in Neurobiology (2021) Vol. 204, pp. 102112-102112
Open Access | Times Cited: 28
Presynaptic Gq-coupled receptors drive biphasic dopamine transporter trafficking that modulates dopamine clearance and motor function
Patrick J. Kearney, Nicholas C. Bolden, Elizabeth Kahuno, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 2, pp. 102900-102900
Open Access | Times Cited: 12
Unraveling correlative roles of dopamine transporter (DAT) and Parkin in Parkinson’s disease (PD) – A road to discovery?
Kaavya Jayaramayya, Mahalaxmi Iyer, Dhivya Venkatesan, et al.
Brain Research Bulletin (2020) Vol. 157, pp. 169-179
Closed Access | Times Cited: 31
A Critical LRRK at the Synapse? The Neurobiological Function and Pathophysiological Dysfunction of LRRK2
Naila Kuhlmann, Austen J. Milnerwood
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 29
Formation of retromer transport carriers is disrupted by the Parkinson disease‐linked Vps35 D620N variant
Yi Cui, Zhe Yang, Neftali Flores‐Rodriguez, et al.
Traffic (2020) Vol. 22, Iss. 4, pp. 123-136
Open Access | Times Cited: 28
Role of dopamine neuron activity in Parkinson's disease pathophysiology
Katerina Rademacher, Ken Nakamura
Experimental Neurology (2023) Vol. 373, pp. 114645-114645
Open Access | Times Cited: 10
Emergent glutamate & dopamine dysfunction in VPS35(D620N) knock-in mice and rapid reversal by LRRK2 inhibition
Anusha Kamesh, Chelsie Kadgien, Naila Kuhlmann, et al.
Research Square (Research Square) (2025)
Closed Access
Emergent glutamate & dopamine dysfunction in VPS35(D620N) knock-in mice and rapid reversal by LRRK2 inhibition
Anusha Kamesh, Chelsie Kadgien, Naila Kuhlmann, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top